Citadel Advisors
NHTC icon

Citadel Advisors’s Natural Health Trends NHTC Stock Holding History

Citadel Advisors’s Portfolio NHTC Stock Details NHTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$67.1K Buy
37,888
+4,474
+13% +$11.7K ﹤0.01% 12967
2026
Q1 		$93.2K Sell
33,414
-27,457
-45% -$91.8K ﹤0.01% 12073
2025
Q4 		$188K Buy
+60,871
New +$221K ﹤0.01% 11088
2025
Q3 		– Sell
-15,616
Closed -$69.3K – 13656
2025
Q2 		$69.3K Buy
+15,616
New +$74.9K ﹤0.01% 11595
2025
Q1 		– Sell
-7,820
Closed -$36.1K – 15231
2024
Q4 		$36.1K Buy
7,820
+1,945
+33% +$10.6K ﹤0.01% 12706
2024
Q3 		$35K Sell
5,875
-13,657
-70% -$93.5K ﹤0.01% 12291
2024
Q2 		$139K Buy
19,532
+1,976
+11% +$13.5K ﹤0.01% 10461
2024
Q1 		$118K Buy
17,556
+10,010
+133% +$62.5K ﹤0.01% 11132
2023
Q4 		$44.1K Sell
7,546
-281
-4% -$1.54K ﹤0.01% 11911
2023
Q3 		$41.9K Buy
+7,827
New +$42.6K ﹤0.01% 11955
2023
Q1 		– Sell
-18,935
Closed -$64.4K – 15219
2022
Q4 		$64.4K Buy
18,935
+6,137
+48% +$23.4K ﹤0.01% 11817
2022
Q3 		$47K Buy
+12,798
New +$64.5K ﹤0.01% 11678
2021
Q3 		– Sell
-11,049
Closed -$77K – 14372
2021
Q2 		$77K Buy
+11,049
New +$79.9K ﹤0.01% 13102
2019
Q4 		– Sell
-11,402
Closed -$72.9K – 9519
2019
Q3 		$81K Sell
11,402
-5,735
-33% -$42.1K ﹤0.01% 8569
2019
Q2 		$138K Sell
17,137
-37,253
-68% -$389K ﹤0.01% 8397
2019
Q1 		$704K Buy
+54,390
New +$811K ﹤0.01% 6208
2018
Q4 		– Sell
-10,396
Closed -$229K – 9556
2018
Q3 		$242K Buy
+10,396
New +$255K ﹤0.01% 7931
2017
Q2 		– Sell
-12,428
Closed -$355K – 7864
2017
Q1 		$359K Buy
+12,428
New +$334K ﹤0.01% 5597
2016
Q2 		– Sell
-6,136
Closed -$200K – 7198
2016
Q1 		$203K Sell
6,136
-13,125
-68% -$356K ﹤0.01% 5624
2015
Q4 		$646K Buy
19,261
+17,258
+862% +$760K ﹤0.01% 4139
2015
Q3 		$65K Sell
2,003
-9,544
-83% -$289K ﹤0.01% 7376
2015
Q2 		$479K Buy
+11,547
New +$342K ﹤0.01% 5047

Other funds holding NHTC

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Citadel Advisors's NHTC Position: Q2 2026 in Review

Citadel Advisors increased its Natural Health Trends (NHTC) stake by 13% in Q2 2026, buying an estimated $11.7K and bringing the position to 37,888 shares worth $67.1K. The position accounts for ﹤0.01% of the portfolio, ranked #12967.

Citadel Advisors first reported a position in NHTC in Q2 2015 and has held it in 22 quarters since. The position peaked at $704K in Q1 2019. 22 funds tracked by Wall St. Rank hold NHTC as of Q2 2026.

  • Citadel Advisors held 37,888 shares of Natural Health Trends worth $67.1K as of Q2 2026.
  • Citadel Advisors bought 4,474 Natural Health Trends shares in Q2 2026, an estimated $11.7K.
  • Natural Health Trends made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #12967 holding.
  • Citadel Advisors first reported a position in Natural Health Trends in Q2 2015 and has held it in 22 quarters since.
  • Citadel Advisors's Natural Health Trends position peaked at $704K in Q1 2019.
  • 22 funds tracked by Wall St. Rank held Natural Health Trends as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.